Pulse wave velocity, intima media thickness, and flow-mediated dilatation in patients with normotensive normoglycemic inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 21, Issue 6, 2015, Pages 1314-1320

  Ozturk, Kadir ^a   Guler, Ahmet Kerem ^b   Cakir, Mehmet ^b   Ozen, Alptug ^c   Demirci, Hakan ^a   Turker, Turker ^a   Demirbas, Seref ^b   Uygun, Ahmet ^a   Gulsen, Mustafa ^a   Bagci, Sait ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b Departments of Internal Medicine Nephrology   (United States)

^c Departments of Radiology   (United States)

Author keywords

arterial stiffness; atherosclerosis; endothelial dysfunction; Inflammatory bowel disease

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; GLUCOSE BLOOD LEVEL;

ADULT; ARTERIAL WALL THICKNESS; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; ATHEROSCLEROSIS; BRACHIAL ARTERY; CAROTID ARTERY BIFURCATION; COLITIS; COMMON CAROTID ARTERY; CONTROLLED STUDY; CROHN DISEASE; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; ENDOTHELIAL DYSFUNCTION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEMORAL ARTERY; HEMOGLOBIN BLOOD LEVEL; HUMAN; ILEITIS; ILEOCOLITIS; INFLAMMATORY BOWEL DISEASE; LEFT COMMON CAROTID ARTERY; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PANCOLITIS; PRIORITY JOURNAL; PROCTITIS; PULSE WAVE; RIGHT COMMON CAROTID ARTERY; THROMBOCYTE; ULCERATIVE COLITIS; BLOOD PRESSURE; CASE CONTROL STUDY; COMPLICATION; DILATATION; GLUCOSE BLOOD LEVEL; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RISK FACTOR; STATISTICS AND NUMERICAL DATA; VASODILATATION;

ADULT; ATHEROSCLEROSIS; BLOOD GLUCOSE; BLOOD PRESSURE; BRACHIAL ARTERY; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; CROSS-SECTIONAL STUDIES; DILATATION; FEMALE; HUMANS; MALE; PULSE WAVE ANALYSIS; RISK FACTORS; VASODILATION;

EID: 84929916810     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000355     Document Type: Article

References (40)

1. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004; 126:1504-1517.
2. Yarur AJ, Deshpande AR, Pechman DM, et al. Inflammatory bowel disease is associated with an increased incidence of cardiovascular events. Am J Gastroenterol. 2011;106:741-747.
3. Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003;349:2399-2406.
4. Salmon JE, Roman MJ. Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Am J Med. 2008;121:S3-S8.
5. Athyros VG, Kakafika AI, Karagiannis A, et al. Do we need to consider inflammatory markers when we treat atherosclerotic disease? Atherosclerosis. 2008;200:1-12.
6. Cosnes J, Gower-Rousseau C, Seksik P, et al. Epidemiology and natural history of inflammatory bowel disease. Gastroenterology. 2011;140: 1785-1794.
7. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004;350:1387-1397.
8. Rho YH, Chung CP, Oeser A, et al. Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum. 2009;61:1580-1585.
9. Ridker PM, Buring JE, Shih J, et al. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation. 1998;25:731-733.
10. Chung CP, Oeser A, Solus JF, et al. Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms. Arthritis Rheum. 2008;58: 2105-2112.
11. Schultz O, Oberhauser F, Saech J, et al. Effects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseases. PLoS One. 2010;5:e14328.
12. Theocharidou E, Gossios TD, Giouleme O, et al. Carotid intima-media thickness in patients with inflammatory bowel disease: a systematic review. Angiology. 2014;65:284-293.
13. Kayahan H, Sari I, Cullu N, et al. Evaluation of early atherosclerosis in patients with inflammatory bowel disease. Dig Dis Sci. 2012;57: 2137-2143.
14. Otsuka K, Fukuda S, Shimada K, et al. Serial assessment of arterial stiffness by cardio-ankle vascular index for prediction of future cardiovascular events in patients with coronary artery disease. Hypertens Res. 2014;37:1014-1020.
15. Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:2588-2605.
16. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55:1318-1327.
17. Akdogan RA, Durakoglugil ME, Kocaman SA, et al. Increased pulse wave velocity and carotid intima-media thickness in patients with ulcerative colitis. Dig Dis Sci. 2013;58:2293-2300.
18. Zanoli L, Cannavò M, Rastelli S, et al. Arterial stiffness is increased in patients with inflammatory bowel disease. J Hypertens. 2012;30: 1775-1781.
19. Zanoli L, Rastelli S, Inserra G, et al. Increased arterial stiffness in inflammatory bowel diseases is dependent upon inflammation and reduced by immunomodulatory drugs. Atherosclerosis. 2014;234:346-351.
20. Korkmaz H, Sahin F, Ipekci SH, et al. Increased pulse wave velocity and relationship with inflammation, insulin, and insulin resistance in inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2014;26: 725-732.
21. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19 (suppl A):5A-36A.
22. Fridewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
23. Bautista LE. Inflammation, endothelial dysfunction, and the risk of high blood pressure: epidemiologic and biological evidence. J Hum Hypertens. 2003;17:223-230.
24. Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236-1241.
25. Luscher TF, Barton M. Biology of the endothelium. Clin Cardiol. 1997; 20:3-10.
26. Schinzari F, Armuzzi A, De Pascalis B, et al. Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease. Clin Pharmacol Ther. 2008;83:70-76.
27. Principi M, Mastrolonardo M, Scicchitano P, et al. Endothelial function and cardiovascular risk in active inflammatory bowel diseases. J Crohns Colitis. 2013;7:e427-e433.
28. Kocaman O, Sahin T, Aygun C, et al. Endothelial dysfunction in patients with ulcerative colitis. Inflamm Bowel Dis. 2006;12:166-171.
29. Touboul PJ, Hennerici MG, Meairs S, et al. Mannheim intima-media thickness consensus. Cerebrovasc Dis. 2004;18:346-349.
30. O'Leary DH, Polak JF, Kronmal RA, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999;340:14-22.
31. Dagli N, Poyrazoglu OK, Dagli AF, et al. Is inflammatory bowel disease a risk factor for early atherosclerosis? Angiology. 2010;61:198-204.
32. van Leuven SI, Hezemans R, Levels JH, et al. Enhanced atherogenesis and altered high density lipoprotein in patients with Crohn's disease. J Lipid Res. 2007;48:2640-2646.
33. Papa A, Santoliquido A, Danese S, et al. Increased carotid intima-media thickness in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2005;22:839-846.
34. Theocharidou E, Gossios TD, Griva T, et al. Is there an association between inflammatory bowel diseases and carotid intima-media thickness? preliminary data. Angiology. 2013;65:543-550.
35. Broide E, Schopan A, Zaretsky M, et al. Intima-media thickness of the common carotid artery is not significantly higher in Crohn's disease patients compared to healthy population. Dig Dis Sci. 2011;56:197-202.
36. Maharshak N, Arbel Y, Bornstein NM, et al. Inflammatory bowel disease is not associated with increased intimal media thickening. Am J Gastroenterol. 2007;102:1050-1055.
37. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999; 340:115-126.
38. Lorenz MW, Markus HS, Bots ML, et al. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;115:459-467.
39. Koivistoinen T, Virtanen M, Hutri-Kähönen N, et al. Arterial pulse wave velocity in relation to carotid intima-media thickness, brachial flowmediated dilation and carotid artery distensibility: the Cardiovascular Risk in Young Finns Study and the Health 2000 Survey. Atherosclerosis. 2012; 220:387-393.
40. Lunder M, Janic M, Kejzar N, et al. Associations among different functional and structural arterial wall properties and their relations to traditional cardiovascular risk factors in healthy subjects: a cross-sectional study. BMC Cardiovasc Disord. 2012;12:29.